An observational study in Trigeminal Neuralgia, Microvascular Decompression Surgery and Post-operative Pain, sponsored by Rutgers, The State University of New Jersey. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-10-14.
Sponsored by Rutgers, The State University of New Jersey · Observational
The goal of this observational study is to learn about the long-term effects of microvascular decompression (MVD) in patients with trigeminal neuralgia (TN). The main question it aims to answer is:
Does undergoing post-operative dental treatment or other orofacial stimulation increase the likelihood of pain relapse after MVD for TN?
Participants who have previously undergone MVD for TN as part of their standard medical care will be asked to complete surveys over phone call. These surveys will focus on their pain experiences, timing, anxiety attacks and nature of any pain relapses, and whether they have received dental treatments or other orofacial interventions during follow-up.
135 studies on the registry are indexed under Trigeminal Neuralgia; 44 are open to participants now.
This study's planned enrollment of 100 is above the median of 82 across 34 observational studies indexed under Trigeminal Neuralgia.
Browse Trigeminal Neuralgia studies →Rutgers, The State University of New Jersey is the lead sponsor of 496 studies on the registry; 130 are open to participants now.
Of its 38 completed or terminated interventional studies of FDA-regulated products, 30 (79%) have results posted.
Counted across the registry records on this site, refreshed daily.
Potential participants will be identified through a review of the post-operative patient database at Robert Wood Johnson University Hospital in New Brunswick, New Jersey. Eligible subjects are individuals who have undergone initial microvascular decompression (MVD) surgery for trigeminal neuralgia. Medical records will be accessed through the EPIC system, with IRB approval in place
Exclusion Criteria:
Pain control following microvascular decompression (MVD)
Pain control will be assessed using the Barrow Neurological Institute (BNI) Pain Scale to evaluate changes in pain severity and relief after MVD.
Time frame: Up to 60 months post-surgery
Plan to share: Undecided — Undecided
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rutgers, The State University of New Jersey